Abbott Laboratories (ABT) Stock Forecast for 2024–2028. Sell or Buy Prediction







Buy or Sell TSLA stocks? (TSLA) forecasting

Tesla: At A Crossroads

May 29, 2024
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Abbott Laboratories (ABT) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 30, 2024 (07:00)

Sector: Healthcare

The share price of Abbott Laboratories (ABT) now

Latest session on the 29th of May for
Abbott Laboratories is negative
Trading Volume: 4961324
Open: 101.09 /  High: 101.77 /  Low: 100.64
What analysts predict: $125.59
52-week High/Low: $121.04 / $88.8

50/200 Day Moving Average: $107.85 / $106.2

This figure corresponds to the Average Price over the previous 50/200 days. For Abbott Laboratories stocks, the 50-day moving average is the resistance level today.

For Abbott Laboratories stocks, the 200-day moving average is the resistance level today.

Are you interested in Abbott Laboratories stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abbott Laboratories stock price in 2024, 2025, 2026, 2027, 2028. How much will one Abbott Laboratories share be worth in 2024 - 2028?

When should I take profit in Abbott Laboratories stock? When should I record a loss on Abbott Laboratories stock? What are analysts' forecasts for Abbott Laboratories stock? What is the future of Abbott Laboratories stock? We forecast Abbott Laboratories stock performance using neural networks based on historical data on Abbott Laboratories stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abbott Laboratories stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abbott Laboratories shares. This happens once a day.


Historical and forecast chart of Abbott Laboratories stock

The chart below shows the historical price of Abbott Laboratories stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abbott Laboratories stock price can be found in the table below.

Long-term forecasts by years.

Unlocking Abbott Laboratories' Stock Future: A Comprehensive ABT Stock Forecast

Trend: Bullish
May 18, 2024

For investors asking, "is ABT a good stock to buy?" or pondering the ABT stock buy or sell dilemma, insight into future stock rate changes is invaluable. The financial landscape of Abbott Laboratories (ABT) is set for intriguing shifts, driven by a trio of pivotal factors identified as instrumental in influencing its stock price trajectory. Understanding these can significantly enhance the accuracy of ABT stock price predictions and assist in decision-making on whether to buy or sell Abbott Laboratories stock.

Decoding Impactful Factors for an Astute ABT Stock Price Target

Analysts and investors alike eye the base business growth, financial strength, and current valuation of ABT as prime indicators of its stock performance potential. The consistent double-digit organic sales growth in ABT’s base business, notably in segments not related to COVID-19 testing, is a robust driver of positive momentum. This growth, fueled by innovative product introductions and expansions in market territory and reimbursement coverage, promises a bright outlook for sales and earnings — laying the groundwork for an encouraging ABT stock forecast.

Abbott Laboratories' formidable financial posture, highlighted by an AA- credit rating and a high interest coverage ratio, casts a reassuring glow on its stability and capacity for sustained growth. Such financial health not only bolsters investor confidence but also strengthens the case for ABT as a secure investment choice, impacting the ABT stock price prediction in a positive light.

Lastly, the allure of valuation cannot be overstated. With ABT stock currently perceived as trading below its fair value, savvy investors are presented with a potentially lucrative buying opportunity. The anticipated correction towards fair value could propel the ABT stock price target upward, making the question of "ABT stock buy or sell" lean heavily towards a buy recommendation for those looking at long-term gains.

In summary, by dissecting these factors — base business growth, financial strength, and valuation — analytics wield a powerful trio of tools in forecasting ABT's stock rates. For anyone researching "why ABT stock down" or seeking an "ABT stock price prediction," focusing on these areas offers the clearest insights into future stock performance, rendering Abbott Laboratories an attractive proposition in the landscape of dividend growth stocks.

Review the original Analysis
About author

Unlocking the Future of ABT Stock: Growth, Dividends, and Inflation Insights

Trend: Bullish
Apr 22, 2024

As analysts keep a keen eye on Abbott Laboratories (ABT), several core factors emerge as pivotal in forecasting the ABT stock price target. At the forefront, ABT's remarkable performance and growth in its core business segments, including Nutrition and Medical Devices, set a robust stage for optimistic ABT stock forecasts. This growth trajectory, bolstered by a recent guidance hike and upbeat earnings outlook, positions ABT as a potentially lucrative investment.

Dividends and Inflation: A Dual-Threat Strategy

For those pondering 'is ABT a good stock to buy?', consider the company's consistent dividend growth and yield. These attributes not only cater to income-focused investors but, combined with capital appreciation, offer a compelling argument for why ABT could see positive stock price movements. However, the journey isn't devoid of hurdles. Inflation concerns within the healthcare industry and ongoing valuation challenges, especially related to COVID-19 uncertainties, pose questions such as 'why ABT stock down?' at times of volatility.

An adept analyst will weigh these factors meticulously, using them to sculpt an informed ABT stock price prediction. By assessing ABT's resilience in navigating inflationary pressures, alongside its competitive stance and growth dynamics, analysts aim to craft the most accurate buy or sell Abbott Laboratories stock recommendations. Ultimately, whether ABT stock buy or sell leans, hinges on carefully balancing optimism with the caution dictated by competition and global health uncertainties.

In conclusion, ABT stands at a fascinating juncture, with its fate in the stock market swayed by various forces. For investors and analysts alike, the careful dissection of these influences provides a pathway to predicting and benefiting from ABT's stock movements in the near future.

Review the original Analysis
About author

Predicting Shifts in ABT Stocks: Unpacking the Future of Abbott Laboratories

Trend: Bullish
Apr 17, 2024

The ever-evolving landscape of Abbott Laboratories (ABT) stock presents a fascinating study in how internal and external factors intersect to shape investor sentiment and stock performance. As we gaze into the company's financial future, several key drivers emerge as pivotal in influencing ABT stock rates. First and foremost, organic growth in sales and revenue for Abbott Laboratories holds the beacon of potential, standing as a primary indicator of the company's robust market presence and competitive edge. A keen analyst eyeing the ABT stock forecast would weigh this factor heavily in their predictions.

Insights into Vaccine-Driven Volatility and Innovation Impact

Another significant aspect to consider is the rollercoaster ride of COVID-19 testing-related revenue. Given the pandemic's unpredictable nature, shifts in testing demands could serve as a wildcard, occasionally jolting the ABT stock price prediction in short-term windows. Similarly, the commercial performance and adoption rates of new product releases, such as the GLP Systems Track and PROTALITY line, provide a narrative of innovation and growth potential crucial for any ABT stock buy or sell decision.

Lastly, how well Abbott Laboratories' projections align with analyst expectations can either buoy or burden its stock value. Misalignments may lead to analyst downgrades, influencing whether market actors view ABT as a good stock to buy or a sell signal. Therefore, accurate ABT stock price targets hinge on an analyst's capacity to interpret these varied dimensions—organizational growth, product performance, market trends, and fiscal guidance—with discernment.

  • Organic growth in sales and revenue for Abbott Laboratories
  • COVID-19 testing-related revenue fluctuations
  • Adoption and success of new product launches
  • Alignment between corporate guidance and analyst expectations

For investors delving into the Abbott Laboratories stock forecast or contemplating the ABT stock price prediction, focusing on these critical factors could unveil the trajectory of ABT stocks, enabling informed decisions in this unpredictable yet promising market landscape.

Review the original Analysis
About author

Abbott Laboratories manufactures drugs, medical devices and diagnostic tools – tests for immunity and blood tests that are used in clinics and hospitals in N countries. The first HIV test was developed by Abbott.

Business publications and major stock indices recognize Abbott Laboratories’ contributions: Fortune magazine has ranked the company as one of the most respected in the world every year since 1984.

The company was founded in 1888. The University of Michigan graduate Wallace Abbott worked as a medical practitioner and opened his own pharmacy. He introduced a new way of using alkaloids of medicinal plants: he formed granules from them with micro doses. Treatment with these granules helped patients because the doses of the drug were accurate and the effect was predictable and consistent.

Official site of the company

Abbott Laboratories daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 01 103.45 102.68 104.71 1.98
Jun 02 103.37 101.81 104.52 2.66
Jun 03 102.87 101.92 103.90 1.94
Jun 04 103.24 102.76 104.85 2.03
Jun 05 105.22 104.15 105.64 1.43
Jun 06 107.20 106.23 108.81 2.42
Jun 07 106.54 105.47 107.81 2.22
Jun 08 106.81 106.26 108.18 1.81
Jun 09 104.76 103.29 105.56 2.19
Jun 10 104.15 102.95 104.70 1.70
Jun 11 104.90 103.64 105.87 2.15
Jun 12 105.99 105.17 107.08 1.81
Jun 13 107.25 106.82 108.77 1.83
Jun 14 107.48 106.45 108.49 1.92
Jun 15 108.62 108.01 109.99 1.83
Jun 16 109.92 108.82 111.37 2.34
Jun 17 109.11 107.36 110.27 2.70
Jun 18 110.05 109.61 111.55 1.77
Jun 19 109.81 108.62 111.48 2.63
Jun 20 108.71 107.43 109.99 2.39
Jun 21 107.80 107.00 108.29 1.21
Jun 22 107.08 106.10 108.69 2.44
Jun 23 106.66 105.80 107.57 1.67
Jun 24 107.77 106.36 109.08 2.55
Jun 25 108.48 107.76 109.71 1.81
Jun 26 110.43 109.32 111.60 2.08
Jun 27 109.06 108.60 110.13 1.41
Jun 28 108.78 108.21 109.34 1.05
Jun 29 107.78 107.00 109.03 1.89
Jun 30 105.62 104.99 106.91 1.83

Abbott Laboratories Daily Price Targets


Abbott Laboratories Stock Forecast 06-01-2024.

Forecast target price for 06-01-2024: $103.45.
Positive dynamics for Abbott Laboratories shares will prevail with possible volatility of 1.937%.
Pessimistic target level: 102.68
Optimistic target level: 104.71

Abbott Laboratories Stock Forecast 06-02-2024.

Forecast target price for 06-02-2024: $103.37.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 2.591%.
Pessimistic target level: 101.81
Optimistic target level: 104.52

Abbott Laboratories Stock Forecast 06-03-2024.

Forecast target price for 06-03-2024: $102.87.
Negative dynamics for Abbott Laboratories shares will prevail with possible volatility of 1.901%.
Pessimistic target level: 101.92
Optimistic target level: 103.90

Abbott Laboratories Stock Forecast 06-04-2024.

Forecast target price for 06-04-2024: $103.24.
Positive dynamics for Abbott Laboratories shares will prevail with possible volatility of 1.989%.
Pessimistic target level: 102.76
Optimistic target level: 104.85

Abbott Laboratories Stock Forecast 06-05-2024.

Forecast target price for 06-05-2024: $105.22.
Positive dynamics for Abbott Laboratories shares will prevail with possible volatility of 1.414%.
Pessimistic target level: 104.15
Optimistic target level: 105.64

Abbott Laboratories Stock Forecast 06-06-2024.

Forecast target price for 06-06-2024: $107.20.
Positive dynamics for Abbott Laboratories shares will prevail with possible volatility of 2.365%.
Pessimistic target level: 106.23
Optimistic target level: 108.81

ABT (ABT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 104.92 98.46 106.60 7.64
Jul. 113.06 109.72 118.40 7.33
Aug. 116.95 111.06 121.26 8.41
Sep. 118.92 115.02 124.62 7.71
Oct. 116.44 111.13 119.52 7.01
Nov. 114.86 108.98 119.73 8.98
Dec. 117.25 114.34 121.00 5.50

Abbott Laboratories forecast for this year


Abbott Laboratories Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $104.92. Pessimistic: $98.46. Optimistic: $106.60


Abbott Laboratories Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $113.062. Pessimistic: $109.72. Optimistic: $118.40


Abbott Laboratories Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $116.952. Pessimistic: $111.06. Optimistic: $121.26


Abbott Laboratories Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $118.916. Pessimistic: $115.02. Optimistic: $124.62


Abbott Laboratories Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $116.443. Pessimistic: $111.13. Optimistic: $119.52


Abbott Laboratories Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $114.859. Pessimistic: $108.98. Optimistic: $119.73


Abbott Laboratories Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $117.248. Pessimistic: $114.34. Optimistic: $121.00



Abbott Laboratories (ABT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 113.40 111.50 119.39 6.61
Mar 116.67 110.60 123.30 10.29
Mar 124.88 121.59 131.98 7.87
Apr 118.59 116.41 123.62 5.83
May 113.56 111.47 120.28 7.33
Jun 121.83 118.32 128.94 8.24
Jul 120.27 113.15 125.75 10.02
Aug 115.94 108.52 120.58 10.00
Sep 111.30 107.47 113.17 5.03
Oct 110.32 104.23 116.32 10.39
Nov 116.50 114.64 123.68 7.31
Dec 119.39 114.52 122.16 6.26

Abbott Laboratories (ABT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 117.00 113.63 122.99 7.61
Mar 121.68 117.20 124.60 5.94
Mar 119.54 113.99 123.65 7.81
Apr 123.56 119.31 128.79 7.37
May 129.88 127.49 138.09 7.67
Jun 137.47 133.07 140.22 5.10
Jul 140.88 136.26 148.99 8.55
Aug 150.46 146.12 152.86 4.41
Sep 148.29 140.22 154.81 9.42
Oct 153.75 146.37 160.02 8.53
Nov 144.64 139.78 152.74 8.48
Dec 145.92 143.47 149.65 4.13

Abbott Laboratories (ABT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 155.72 151.74 165.56 8.35
Mar 160.58 155.57 164.31 5.32
Mar 171.63 164.08 176.43 7.00
Apr 172.59 168.31 182.12 7.58
May 165.96 162.38 175.26 7.35
Jun 167.16 157.40 170.37 7.61
Jul 175.32 166.76 184.57 9.65
Aug 176.72 171.91 184.49 6.82
Sep 178.41 170.14 185.98 8.52
Oct 176.13 167.54 182.19 8.04
Nov 182.61 175.16 193.13 9.30
Dec 184.37 173.01 193.80 10.73

Abbott Laboratories (ABT) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 196.31 185.00 203.07 8.89
Mar 188.62 179.86 197.07 8.73
Mar 188.62 181.22 192.24 5.73
Apr 199.48 189.75 211.77 10.40
May 206.18 194.64 211.30 7.88
Jun 212.78 200.87 225.38 10.88
Jul 221.63 216.14 231.92 6.80
Aug 213.30 199.99 218.93 8.65
Sep 203.57 195.10 211.39 7.70
Oct 208.62 201.61 219.30 8.07
Nov 213.13 207.50 219.78 5.59
Dec 217.05 204.37 225.73 9.46

Abbott Laboratories information and performance

Abbott Laboratories Address

100 ABBOTT PARK ROAD, ABBOTT PARK, IL, US

Market Capitalization: 177 355 276 000 $

Market capitalization of the Abbott Laboratories is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABT shares in the company outstanding by the market price of one share.

EBITDA: 10 368 000 000 $

EBITDA of Abbott Laboratories is earnings before interest, income tax and depreciation of assets.

PE Ratio: 32.37

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 5.99

Price/earnings to growth

DPS: 2.12

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0212

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.15

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.067
Quarterly Revenue Growth YOY: 0.022
Trailing PE: 32.37

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 23.64

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.928

Enterprise Value (EV) /Revenue

EV To EBITDA: 18.75

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1739630000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Abbott Laboratories (ABT) stock dividend

Abbott Laboratories last paid dividends on 04/12/2024. The next scheduled payment will be on 05/15/2024. The amount of dividends is $2.12 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.